NEC selected by AMED for design of a universal vaccine that is effective against influenza virus strains

Source :: JCN Newswires. September 14, 2023
Publication Year :: 2023
Abstract: TOKYO, Sept 14, 2023 - (JCN Newswire) - NEC Corporation (TSE: 6701) has been selected to participate in a vaccine/new modality research and development project beginning in FY2023. NEC was [...]

Subjects :: NEC Corp. -- Technology application
Medical research -- Technology application
Medicine, Experimental -- Technology application
Influenza vaccines -- Technology application
Influenza -- Technology application
Computer industry -- Technology application
Viral proteins -- Technology application
Industrial research -- Japan
Research and development
Microcomputer industry
Technology application
Computer industry
Business, general

Tools